Navigation Links
Surveyed U.S. Payers Are Significantly More Likely To Reimburse Biosimilars Developed By Multinational Manufacturers Compared With Those Developed By Regional Emerging Market Players
Date:7/22/2013

aid BioTrends Research Group Senior Director, Andrew Merron Ph.D.  "Compared with payers who believe brands and biosimilars are only somewhat similar, a greater proportion of surveyed payers who say brands and biosimilars are very similar expect to add biosimilars to their formulary within six months of launch. This finding suggests that the greater the perceived level of similarity, the faster the predicted speed of uptake."

The Biosimilars Advisory Service provides insight and analysis that is vital to successful business planning in the rapidly evolving biosimilars space. The service includes quarterly webinars detailing major developments, analyst insight addressing key market changes and opportunities, therapeutic area-specific primary research and forecasting modules.

About BioTrends Research Group
BioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please visit www.bio-trends.com. BioTrends is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks of their respective holders.

For more information, contact:

Decision Resources Group
Christopher Comfort
781-993-2597
ccomfort@dresources.com

 


'/>"/>
SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Surveyed Physicians Indicate that Xtandi is Prescribed to Nearly One Quarter of Metastatic Castrate-Resistant Prostate Cancer Patients Who Have Failed to Respond to Prior Docetaxel Treatment
2. At Three Months Post Launch, Two-Thirds of Surveyed U.S. Rheumatologists Believe that Initiations of Pfizers Xeljanz in the Rheumatoid Arthritis Treatment Algorithm Will Occur Following at Least Two Biologic Failures
3. Don't Forget the Payer in Your Digital Strategy: What Payers Need and Want from Pharma
4. Trending HealthEconomics.Com Pharma Pricing, Reimbursement, and Health Policy Stories Show Healthcare Payers Aren’t Taking Drug Prices Laying Down
5. SentoClone International AB Significantly Strengthens its Global Patent Portfolio Covering its Clinical Stage Sentinel Node-derived CD4 T-cell Cancer Therapy
6. Consumer Survey Indicates Mouth Guards Worsen TMJ Symptoms As Often As Significantly Improving Them – Holistic Technologies
7. U of T engineering breakthrough promises significantly more efficient solar cells
8. SHL to Invest 40 Million USD in 2013 to Significantly Expand Production Facilities
9. VIC Investor Network to Significantly Accelerate Technology Company Growth
10. Phase II Data Presented at ACNP 2012 Shows Novel Antidepressant GLYX-13 Significantly Reduces Depression Scores Within Hours
11. Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardiums New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... NEW YORK , March 31, ... ), a biopharmaceutical company advancing protein biologic therapies ... its Korean marketing partner, Hanmi Pharmaceutical Co., Ltd ... Korea from the country,s Ministry of Food and ... Research Institute (KTR) for MuGard, its oncology supportive-care ...
(Date:3/31/2015)... Lighthouse Information Systems, Inc., a West ... Oregon, Washington and clients across the US, announces ... (M&A) Integration Services offering, effective immediately. ... M&A Integration Practice Leader at Lighthouse, explains, “Research ... M&A initiatives fail to achieve their intended economic ...
(Date:3/30/2015)... , March 30, 2015  NuGene International, ... subsidiary corporation, NuGene BioPharma, Inc. has added another ... Dr. Guan is an internationally recognized researcher ... his college education at Peking University, ... degree from the University of North Carolina, Chapel ...
(Date:3/30/2015)... Md. , March 30, 2015    ... leader in synthetic biology, and Merck Serono, the ... Germany , today announced an exclusive strategic ... Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. This ... develop innovative therapies that modulate the immune system,s ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Lighthouse Information Systems, Inc., Announces Addition of M&A Integration Services 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4
... A. How is fold amplification , ... using the Van Gelder and Eberwine ... an oligo(dT) primer containing the T7 RNA polymerase , ... at the end of mRNA sequences serves as the substrate for the , ...
... , Quantitate gene ... 5 minute cell lysis , ... monitoring , siRNA-induced knockdown , ... Gene Expression Assays and SYBR Green , ...
... , , ... and validation Screening for miRNAs that regulate target , ... cellular process , ... RNAs that are expressed in animals and plants and affect the , ...
Cached Biology Technology:RNA Amplification for Array Analysis 2RNA Amplification for Array Analysis 3RNA Amplification for Array Analysis 4Ready for Real-time in 5 Minutes 2Ready for Real-time in 5 Minutes 3Ready for Real-time in 5 Minutes 4Ready for Real-time in 5 Minutes 5Ready for Real-time in 5 Minutes 6Precursor miRNAs for Successful miRNA Functional Studies 2Precursor miRNAs for Successful miRNA Functional Studies 3Precursor miRNAs for Successful miRNA Functional Studies 4Precursor miRNAs for Successful miRNA Functional Studies 5Precursor miRNAs for Successful miRNA Functional Studies 6Precursor miRNAs for Successful miRNA Functional Studies 7Precursor miRNAs for Successful miRNA Functional Studies 8Precursor miRNAs for Successful miRNA Functional Studies 9Precursor miRNAs for Successful miRNA Functional Studies 10Precursor miRNAs for Successful miRNA Functional Studies 11
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... the "Global Iris Recognition Market 2015-2019" report ... Global Iris Recognition market to grow at a CAGR ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... Levanger, Norway and Boulder, CO, USA -- April 10, ... a new collaboration to advance the clinical use of ... of biomarkers for the prediction of cardiovascular events such ... collaboration will analyze biological samples and clinical data from ...
... N.M. An air sampler the size of an ear ... to improve computer climate models. "We now have an ... said Sandia National Laboratories researcher Ron Manginell, lead author of ... , the often-cited journal of the American Institute of Physics. ...
... Alzheimer,s disease (AD) is now the sixth leading cause of death ... of 65. There is currently no treatment that alters the course ... changes in the way the body handles iron and other metals ... AD symptoms. A new study shows that reducing iron levels in ...
Cached Biology News:Miniature Sandia sensors may advance climate studies 2Miniature Sandia sensors may advance climate studies 3Miniature Sandia sensors may advance climate studies 4Miniature Sandia sensors may advance climate studies 5Antioxidant may disrupt Alzheimer's disease process 2
Request Info...
These macrocarriers are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 macrocarriers....
... [pTyr 209/ pSer 211 ] affinity isolated ... Dulbecco's phosphate buffered saline (without Mg 2+ ... mg/ml BSA (IgG and protease free) and 0.05% ... the region of mouse Hck that contains tyrosine ...
High voltage electrophoresis power supply...
Biology Products: